Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients

Author(s):  Zur Eyal

Issue:  Jan/Feb 2013 - Volume 17, Number 1
View All Articles in Issue

Page(s):  10-22

Download in electronic PDF format for $65

Abstract:  Compounding pharmacists throughout the world are compounding a special type of capsule called "slow-release." This type of capsule is a compounding pharmacy application of the commercial hydrophilic matrix tablets. It is a relatively simple system that allows formulating a robust, reliable, and consistent drug system based on 30% w/w to 40% w/w of specific types of hydroxypropyl methylcellulose. The main purpose of these capsules is to attenuate the drug release when there is a clinical need and no commercial medication exists. Five in vitro trials verified and proved this kind of preparation can be compounded by specialized pharmacists achieving substantial attenuation of drug release that resembles the pharmacokinetic profiles of commercial slow-release medications. An in-depth explanation of the mechanism of action of the slow-release capsules is provided. Since the pharmaceutical calculations needed to compound this preparation are time consuming, a suggestion of a faster way to perform these calculations by using a special Excel spreadsheet is provided. The article demonstrates a special table with a comparison between the specifications, results, and conclusions of the five in vitro trials that evaluated the pharmacokinetic rates of compounded slow-release capsules. The regulatory aspect of compounding slow-release capsules is also discussed.

Related Keywords: Eyal Zur, RPh, MBA, slow-release capsules, hydrophilic matrix tablets, hydroxypropyl methylcellulose, HPMC, attenuated drug release, calculation tool, software, spreadsheet, computer-aided calculations, gel strength, excipients, fillers, liothyronine, T3, formulation, uniformity tests, dissolution tests, regulation, terminology, pharmacokinetics, in vitro trials

Related Categories: EXCIPIENTS, SUPPORT, TECHNOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
Jan/Feb 2013
Pg. 10-22

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix
Timmons Evelyn D
, Timmons Steven P
Sep/Oct 2002
Pg. 379

Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H
, Szwejkowski Jessica, Houston Alana
Sep/Oct 2001
Pg. 401-405

Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 545

Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 547

Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
Nov/Dec 2008
Pg. 548

In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Webster Kathy D
, Al-Achi Antoine, Greenwood Robert
Sep/Oct 1999
Pg. 409-411

Calculations
Prince Shelly J
Jul/Aug 2003
Pg. 294

In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride
Glowiak Dana L
, Green Julie L, Bowman Bill J
Mar/Apr 2005
Pg. 157-164

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions